Joana brings more than 8 years of academic research and experience as well as Scientific writing and editing to her role as a Science and Research writer. She also served as a Postdoctoral Researcher at the Center for Neuroscience and Cell Biology in Coimbra, Portugal, where she also received her PhD in Health Science and Technologies, with a specialty in Molecular and Cellular Biology.
It took longer for advanced melanoma to recur in patients treated with Bristol-Myers Squibb’s Opdivo (nivolumab) than in patients who received Yervoy, according to a Phase 3 clinical trial. The ... Read more
Researchers identified a new biomarker that may help them track cancer response to treatment using a noninvasive positron emission tomography (PET) imaging method. The new method measures granzyme B, ... Read more
Sellas Life Sciences Group is developing the galinpepimut-S vaccine as a potential treatment for patients with cancers ranging from mesothelioma and myeloma to leukemia and ovarian cancer, and is moving forward ... Read more
Oncolytics Biotech is partnering with other companies to develop immunotherapy and immunomodulatory applications for Reolysin, which improved breast cancer survival rates. A combination of Reolysin and the chemotherapy Taxol (paclitaxel) ... Read more
Researchers from the Fred Hutchinson Cancer Research Center talked about recent developments and new research findings in immunotherapy at the American Association for Cancer Research Annual Meeting, Research Propelling Cancer ... Read more
A blood-based cancer test has shown promise in predicting how solid-cancer patients will respond to immunotherapy, according to the test’s developer, Chronix Biomedical. The study, “Tumor Cell-Free DNA Copy Number ... Read more
ATLAS technology, by Genocea Biosciences, may be a useful tool to identify specific molecules in cancer patients that can help develop personalized vaccines, according to new research. These findings ... Read more